A Study to Assess Tolerability, Safety, Pharmacokinetics and Effect of AZP2006 in Patients With PSP
Clinical trial NCT04008355 · COMPLETED
Trial details
- NCT number
- NCT04008355
- Sponsor
- AlzProtect SAS
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-22
- Primary completion
- 2022-07-18
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.